Biotechnology & Pharmaceutical Services Outsourcing Market
Biotechnology & Pharmaceutical Services Outsourcing Market By Service (Product Testing & Validation, Training & Education, Product Design & Development, Product Maintenance, Regulatory Affairs, Consulting), By End Use & By Region - Global Market Insights 2022 to 2032
Analysis of Biotechnology & Pharmaceutical Services Outsourcing Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Biotechnology & Pharmaceutical Services Outsourcing Market Outlook
The global biotechnology and pharmaceutical services outsourcing market is anticipated to hold a market value of US$ 70 Billion in 2022 and US$ 112.31 Billion by 2032. The projected growth rate is nearly 5% during the forecast period from 2022 to 2032.
The outbreak of COVID-19 has had a significant impact on the biotechnology and pharmaceutical services outsourcing market. The situation resulted in delays, terminations, and suspensions of trials. More than 330,000 clinical trials registered on clinicaltrials.gov are at risk due to the spread of novel coronavirus.
| Report Attributes | Details |
|---|---|
| Estimated Market Value in 2022 | US$ 70 Billion |
| Estimated Market Value in 2032 | US$ 112.31 Billion |
| Projected CAGR from 2022 to 2032 | 5% |
| Key Players Profiled | GMP Pharmaceuticals Pty Ltd; The Quantic Group; IQVIA; Lachman Consultant Services, Inc.; Parexel International Corporation; Charles River Laboratories; Concept Heidelberg GmbH; Covance Inc.; ICON plc.; PRA Health Sciences; Biotech |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Revenue Analysis of Biotechnology and Pharmaceutical Services Outsourcing Market 2017 to 2021 vs. Future Outlook 2022 to 2032
The global biotechnology and pharmaceutical services outsourcing market garnered US$ 65 Billion in 2021, expanding at a historical CAGR of 4.2%. The outsourcing services help in overcoming trade barriers and help the organizations to enter international markets. Several firms prefer to outsource services than invest capital and hire a workforce, thereby, providing significant opportunities for expansion.
Biotechnology and pharmaceutical companies are adopting the consulting services owing to factors such as; the growing number of discrepancies in intellectual property rights and fraudulent cases. Owing to such causes, the adoption of these services is on a rise, making it a lucrative market for the players. The estimation reveals that the industry is projected to secure a market value of US$ 112.31 Billion by 2032.
What are the factors boosting the Global Biotechnology and Pharmaceutical Services Outsourcing Market?
Growing Demand for Low-Cost Drug Development to Boost Medical Outsourcing
Contract research and manufacturing allow low-cost product manufacturing and development. The growing application of machine learning-based platforms such as; automation in drug manufacturing, artificial intelligence, and innovative trial designs are anticipated to transform the CMO and CRO sphere in the forecast period.
Furthermore, such medical outsourcing allows cost-saving to their clients and could offer economic benefits in the long run. In addition, outsourcing of pharma helps in saving time utilized in the management and operations of production, thereby, benefitting the industry during the forecast period.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
How does Increasing R&D help the Growth of Outsourcing in the Pharmaceutical Industry?
Growing R&D on Large Molecules to Benefit Outsourcing in Pharmaceutical Industry
Globally, the pharmaceutical industry has the second-highest R&D expenditure against any other sector. The expenses on R&D are increasing during the forecast period, thereby benefiting the market.
As per Evaluate Pharma 2019 report, the pharmaceutical R&D expense was around US$ 179 Billion in 2018. The projected growth rate of the market is 3%. Furthermore, the increasing R&D expenditure on large molecules is predicted to offer significant opportunities for expansion in the forthcoming period.
Country-Wise Analysis
What is the Contribution of North America in Increasing Demand for Outsourcing Pharma?
Presence of Established Players to Boost the Outsourcing in Pharmaceutical Industry in the Region
As per the estimations at Fact.MR, North America is projected to account for the maximum revenue share of 53% in 2022. The development of the industry in the region can be attributed to the presence of established players in North America.
Implementation of stringent strict policies and the growing R&D investments by pharma companies are likely to augment the market in the coming time. In addition, approvals by FDA are likely to offer significant opportunities to the key players. For instance, Bora Pharmaceuticals received FDA approval in 2019, which strengthened its market influence outside Asia.
What is the Growth Outlook for Biotechnology & Pharmaceutical Services Outsourcing in the Asia Pacific?
Increasing Investments by Developed Countries to Boost Medical Outsourcing Services in APAC
APAC is expected to expand at a CAGR of 5.5% during the forecast period, says Fact.MR. The growth of the market in the region can be attributed to the increasing investment by developed nations in the region. Further, several reforms brought in by regulatory bodies to align with the standards of various other countries are likely to offer significant opportunities to the key players.
In addition, the low-cost drug development and availability of a cheaper workforce in the region are predicted to augment the market in APAC. Moreover, the high scope of cost savings, the rapid growth of the biotechnology and pharmaceutical sector, and skilled personnel are other salient causes propelling the market in the region.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Category-Wise Insights
What is the Contribution of the Pharma Segment in Boosting the Growth of the Market?
Increased R&D to Develop Novel Products to Boost the Growth of Outsourcing Pharma Industry
Fact.MR says that the pharma segment is predicted to secure the largest market share of 55%. The segment is anticipated to record a CAGR of 5% during the review period. The expansion can be attributed to the increased R&D by the key players to develop novel products and the growing investments by CROs for the development core capabilities are likely to propel the market growth in the forthcoming period.
Moreover, the manufacturing services offered by CROs and CMOs such as; clinical development, preclinical development, commercial development, high-speed automation, and precision injection moulding are other salient causes boosting the growth of the outsourcing pharma industry.
What is the Role of the Consulting Segment in Propelling the Market?
Increasing M&A activities to Boost the Services Segment and Benefit the Outsourcing Pharma Industry
As per the observations at Fact.MR, the consulting services segment is expected to secure the largest market share of 19%. The domination of the segment can be attributed to growing M&A activities.
The other services segment is anticipated to exhibit a CAGR of 6% during the forecast period. The growth of the segment can be attributed to the increasing outsourcing of generics and biosimilar manufacturing as CMOs provide services at a cheaper cost.
Startups for Biotechnology & Pharmaceutical Services Outsourcing Market
Some of the key start-ups in the market are -
- IRISYS provides contract pharmaceutical product development and manufacturing services, specializing in formulation R&D and GMP manufacturing of clinical trial materials and specialty pharmaceutical products. The company also offers strategic consulting related to drug development. Recently, IRISYS announced plans to extend GMP manufacturing of sterile drug products for clinical and commercial supply.
- Roivant Sciences develops transformative medicines by building technologies and developing talent. The company offers a diverse pipeline of investigational drugs across an array of therapeutic areas. Moreover, Roivant Sciences leverages and develops nimble and focused biopharmaceutical and health technology companies, including Immunovant, Demavant, Datavant, Aruvant, and others.
Competitive Landscape
The players of the market are focusing to increase their global influence and adopt strategies such as; acquisition, collaboration, and partnerships. Some of the recent key developments among key players are :
- In April 2021, Paraxel International Corporation announced a strategic partnership with Veeva. The partnership aims to increase clinical trials by leveraging process innovation and technology.
- In August 2020, Pfizer signed a three-year agreement with PPD. The agreement aims to offer drug development services.
- IQVIA’s Connected Intelligence Platform, which was introduced in April 2021, is an innovative approach, enabling life sciences customers to discover powerful new insights, drive smarter decision making, and get treatments to patients faster. Connected Intelligence brings together IQVIA’s unique portfolio of capabilities to create intelligent connections across its unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to speed the development and commercialization of innovative medicines that improve patient lives
- In October 2020, MediPharm Labs Corp. announced that it had signed a new white-label supply agreement with Sunco Green Pharmaceutical Pty Ltd. It is MediPharm Labs’ 12th supply agreement. As per the two-year agreement, MediPharm Labs Australia will supply specially formulated CBD and THC Cannabis oil products. It will be sold under the Sunco Green Label
- The Quantic Group® is a pharmaceutical, biotechnology, vaccines and medical device specialty consultant that supports both the industry and governments; services are provided in multiple areas including: regulatory, research, development, manufacturing, and quality operations. For 30 years, The Quantic Group® has supported clients on a global basis, particularly in managing regulatory enforcement actions, which include prevention, remediation and certification of many major industry FDA consent decrees.
Key Market Segments Covered in the Global Biotechnology and Pharmaceutical Services Outsourcing Market
-
By End Use :
- Supervisory Control and Data Acquisition (SCADA)
- Programmable Logic Controller (PLC)
- Distributed Control System (DCS)
- Manufacturing Execution System (MES)
- Industrial Safety
- Plant Asset Management (PAM)
-
By Service :
- Product Testing & Validation
- Training & Education
- Product Design & Development
- Product Maintenance
- Auditing and Assessment
- Regulatory Affairs
- Regulatory Writing & Publishing
- Legal Representation
- Clinical Trial Applications & Product Registration
- Others
- Consulting
- Remediation
- Quality Management Systems Consulting
- Regulatory Compliance
- Others
- Others
-
By Region :
- North America
- Latin America
- Europe
- Asia Pacific
- Middle Eats & Africa
Table of Content
- 1. Executive Summary
- 2. Market Overview
- 3. Market Risks and Trends Assessment
- 4. Market Background and Foundation Data Points
- 5. Key Success Factors
- 6. Global Market Demand Analysis 2017 to 2021 and Forecast, 2022 to 2032
- 7. Global Market Value Analysis 2017 to 2021 and Forecast, 2022 to 2032
- 8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Services
- 8.1. Consulting
- 8.1.1. Regulatory compliance
- 8.1.2. Remediation
- 8.1.3. Quality management systems consulting
- 8.1.4. Others
- 8.2. Auditing and assessment
- 8.3. Regulatory affairs
- 8.3.1. Clinical trial applications & product registration
- 8.3.2. Regulatory writing & publishing
- 8.3.3. Legal representation
- 8.3.4. Others
- 8.4. Product maintenance
- 8.5. Product design & development
- 8.6. Product testing & validation
- 8.7. Training & education
- 8.8. Others
- 8.1. Consulting
- 9. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End Use
- 9.1. Supervisory Control and Data Acquisition (SCADA)
- 9.2. Programmable Logic Controller (PLC)
- 9.3. Distributed Control System (DCS)
- 9.4. Manufacturing Execution System (MES)
- 9.5. Industrial Safety
- 9.6. Plant Asset Management (PAM)
- 10. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region
- 10.1. North America
- 10.2. Latin America
- 10.3. Europe
- 10.4. Asia Pacific
- 10.5. Middle East and Africa (MEA)
- 11. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032
- 12. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032
- 13. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032
- 14. Asia Pacific Market Analysis 2017 to 2021 and Forecast 2022 to 2032
- 15. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032
- 16. Key Countries Market Analysis 2017 to 2021 and Forecast 2022 to 2032
- 17. Market Structure Analysis
- 18. Competition Analysis
- 18.1. Parexel International Corporation
- 18.2. The Quantic Group
- 18.3. IQVIA
- 18.4. Lachman Consultant Services, Inc.
- 18.5. GMP Pharmaceuticals Pty Ltd.
- 18.6. Concept Heidelberg GmbH
- 18.7. Covance Inc.
- 18.8. Charles River Laboratories
- 18.9. PRA Health Sciences
- 18.10. ICON plc
- 18.11. Biotech
- 19. Assumptions and Acronyms Used
- 20. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Value (US$ Mn), By Services, 2017 to 2021
Table 02: Global Market Value (US$ Mn), By Services, 2022 to 2032
Table 03: Global Market Value (US$ Mn), By End Use, 2017 to 2021
Table 04: Global Market Value (US$ Mn), By End Use, 2022 to 2032
Table 05: Global Market, By Region, 2017 to 2021
Table 06: Global Market, By Region, 2022 to 2032
Table 07: North America Market Value (US$ Mn), By Services, 2017 to 2021
Table 08: North America Market Value (US$ Mn), By Services, 2022 to 2032
Table 09: North America Market Value (US$ Mn), By End Use, 2017 to 2021
Table 10: North America Market Value (US$ Mn), By End Use, 2022 to 2032
Table 11: North America Market, By Country, 2017 to 2021
Table 12: North America Market, By Country, 2022 to 2032
Table 13: Latin America Market Value (US$ Mn), By Services, 2017 to 2021
Table 14: Latin America Market Value (US$ Mn), By Services, 2022 to 2032
Table 15: Latin America Market Value (US$ Mn), By End Use, 2017 to 2021
Table 16: Latin America Market Value (US$ Mn), By End Use, 2022 to 2032
Table 17: Latin America Market, By Country, 2017 to 2021
Table 18: Latin America Market, By Country, 2022 to 2032
Table 19: Europe Market Value (US$ Mn), By Services, 2017 to 2021
Table 20: Europe Market Value (US$ Mn), By Services, 2022 to 2032
Table 21: Europe Market Value (US$ Mn), By End Use, 2017 to 2021
Table 22: Europe Market Value (US$ Mn), By End Use, 2022 to 2032
Table 23: Europe Market, By Country, 2017 to 2021
Table 24: Europe Market, By Country, 2022 to 2032
Table 25: Asia Pacific Market Value (US$ Mn), By Services, 2017 to 2021
Table 26: Asia Pacific Market Value (US$ Mn), By Services, 2022 to 2032
Table 27: Asia Pacific Market Value (US$ Mn), By End Use, 2017 to 2021
Table 28: Asia Pacific Market Value (US$ Mn), By End Use, 2022 to 2032
Table 29: Asia Pacific Market, By Country, 2017 to 2021
Table 30: Asia Pacific Market, By Country, 2022 to 2032
Table 31: MEA Market Value (US$ Mn), By Services, 2017 to 2021
Table 32: MEA Market Value (US$ Mn), By Services, 2022 to 2032
Table 33: MEA Market Value (US$ Mn), By End Use, 2017 to 2021
Table 34: MEA Market Value (US$ Mn), By End Use, 2022 to 2032
Table 35: MEA Market, By Country, 2017 to 2021
Table 36: MEA Market, By Country, 2022 to 2032
Table 37: Global Market Incremental $ Opportunity, By Services, 2017 to 2021
Table 38: Global Market Incremental $ Opportunity, By End Use, 2022 to 2032
Table 39: Global Market Incremental $ Opportunity, By Region,2022 to 2032
Table 40: North America Market Incremental $ Opportunity, By Services, 2017 to 2021
Table 41: North America Market Incremental $ Opportunity, By End Use, 2022 to 2032
Table 42: North America Market Incremental $ Opportunity, By Country, 2022 to 2032
Table 43: Latin America Market Incremental $ Opportunity, By Services, 2017 to 2021
Table 44: Latin America Market Incremental $ Opportunity, By End Use, 2022 to 2032
Table 45: Latin America Market Incremental $ Opportunity, By Country, 2022 to 2032
Table 46: Europe Market Incremental $ Opportunity, By Services, 2017 to 2021
Table 47: Europe Market Incremental $ Opportunity, By End Use, 2022 to 2032
Table 48: Europe Market Incremental $ Opportunity, By Country, 2022 to 2032
Table 49: Asia Pacific Market Incremental $ Opportunity, By Services, 2017 to 2021
Table 50: Asia Pacific Market Incremental $ Opportunity, By End Use, 2022 to 2032
Table 51: Asia Pacific Market Incremental $ Opportunity, By Country, 2022 to 2032
Table 52: MEA Market Incremental $ Opportunity, By Services,2017 to 2021
Table 53: MEA Market Incremental $ Opportunity, By End Use,2022 to 2032
Table 54: MEA Market Incremental $ Opportunity, By Country,2022 to 2032
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value (US$ Mn) and Year-on-Year Growth, 2017 to 2032
Figure 02: Global Market Absolute $ Historical Gain (2017 to 2021) and Opportunity (2022 to 2032), US$ Mn
Figure 03: Global Market Share, By Services, 2022 & 2032
Figure 04: Global Market Y-o-Y Growth Projections, By Services to 2022 to 2032
Figure 05: Global Market Attractiveness Index, By Services to 2022 to 2032
Figure 06: Global Market Share, By End Use, 2022 & 2032
Figure 07: Global Market Y-o-Y Growth Projections, By End Use –2022 to 2032
Figure 08: Global Market Attractiveness Index, By End Use to 2022 to 2032
Figure 09: Global Market Share, By Region, 2022 & 2032
Figure 10: Global Market Y-o-Y Growth Projections, By Region to 2022 to 2032
Figure 11: Global Market Attractiveness Index, By Region to 2022 to 2032
Figure 12: North America Market Value (US$ Mn) and Year-on-Year Growth, 2017 to 2032
Figure 13: North America Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 2032), US$ Mn
Figure 14: North America Market Share, By Services, 2022 & 2032
Figure 15: North America Market Y-o-Y Growth Projections, By Services to 2022 to 2032
Figure 16: North America Market Attractiveness Index, By Services to 2022 to 2032
Figure 17: North America Market Share, By End Use, 2022 & 2032
Figure 18: North America Market Y-o-Y Growth Projections, By End Use to 2022 to 2032
Figure 19: North America Market Attractiveness Index, By End Use to 2022 to 2032
Figure 20: North America Market Share, By Country, 2022 & 2032
Figure 21: North America Market Y-o-Y Growth Projections, By Country to 2022 to 2032
Figure 22: North America Market Attractiveness Index, By Country to 2022 to 2032
Figure 23: Latin America Market Value (US$ Mn) and Year-on-Year Growth, 2017 to 2032
Figure 24: Latin America Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 2032), US$ Mn
Figure 25: Latin America Market Share, By Services, 2022 & 2032
Figure 26: Latin America Market Y-o-Y Growth Projections, By Services to 2022 to 2032
Figure 27: Latin America Market Attractiveness Index, By Services to 2022 to 2032
Figure 28: Latin America Market Share, By End Use, 2022 & 2032
Figure 29: Latin America Market Y-o-Y Growth Projections, By End Use to 2022 to 2032
Figure 30: Latin America Market Attractiveness Index, By End Use to 2022 to 2032
Figure 31: Latin America Market Share, By Country, 2022 & 2032
Figure 32: Latin America Market Y-o-Y Growth Projections, By Country to 2022 to 2032
Figure 33: Latin America Market Attractiveness Index, By Country to 2022 to 2032
Figure 34: Europe Market Value (US$ Mn) and Year-on-Year Growth, 2017 to 2032
Figure 35: Europe Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 2032), US$ Mn
Figure 36: Europe Market Share, By Services, 2022 & 2032
Figure 37: Europe Market Y-o-Y Growth Projections, By Services to 2022 to 2032
Figure 38: Europe Market Attractiveness Index, By Services to 2022 to 2032
Figure 39: Europe Market Share, By End Use, 2022 & 2032
Figure 40: Europe Market Y-o-Y Growth Projections, By End Use to 2022 to 2032
Figure 41: Europe Market Attractiveness Index, By End Use to 2022 to 2032
Figure 42: Europe Market Share, By Country, 2022 & 2032
Figure 43: Europe Market Y-o-Y Growth Projections, By Country to 2022 to 2032
Figure 44: Europe Market Attractiveness Index, By Country to 2022 to 2032
Figure 45: MEA Market Value (US$ Mn) and Year-on-Year Growth, 2017 to 2032
Figure 46: MEA Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 2032), US$ Mn
Figure 47: MEA Market Share, By Services, 2022 & 2032
Figure 48: MEA Market Y-o-Y Growth Projections, By Services to 2022 to 2032
Figure 49: MEA Market Attractiveness Index, By Services to 2022 to 2032
Figure 50: MEA Market Share, By End Use, 2022 & 2032
Figure 51: MEA Market Y-o-Y Growth Projections, By End Use to 2022 to 2032
Figure 52: MEA Market Attractiveness Index, By End Use to 2022 to 2032
Figure 53: MEA Market Share, By Country, 2022 & 2032
Figure 54: MEA Market Y-o-Y Growth Projections, By Country to 2022 to 2032
Figure 55: MEA Market Attractiveness Index, By Country to 2022 to 2032
Figure 56: Asia Pacific Market Value (US$ Mn) and Year-on-Year Growth, 2017 to 2032
Figure 57: Asia Pacific Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 2032), US$ Mn
Figure 58: Asia Pacific Market Share, By Services, 2022 & 2032
Figure 59: Asia Pacific Market Y-o-Y Growth Projections, By Services to 2022 to 2032
Figure 60: Asia Pacific Market Attractiveness Index, By Services to 2022 to 2032
Figure 61: Asia Pacific Market Share, By End Use, 2022 & 2032
Figure 62: Asia Pacific Market Y-o-Y Growth Projections, By End Use to 2022 to 2032
Figure 63: Asia Pacific Market Attractiveness Index, By End Use to 2022 to 2032
Figure 64: Asia Pacific Market Share, By Country, 2022 & 2032
Figure 65: Asia Pacific Market Y-o-Y Growth Projections, By Country to 2022 to 2032
Figure 66: Asia Pacific Market Attractiveness Index, By Country to 2022 to 2032
Figure 67: US Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 68: US Market Share, By Services, 2021
Figure 69: US Market Share, By End Use, 2021
Figure 70: Canada Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 71: Canada Market Share, By Services, 2021
Figure 72: Canada Market Share, By End Use, 2021
Figure 73: Brazil Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 74: Brazil Market Share, By Services, 2021
Figure 75: Brazil Market Share, By End Use, 2021
Figure 76: Mexico Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 77: Mexico Market Share, By Services, 2021
Figure 78: Mexico Market Share, By End Use, 2021
Figure 79: Germany Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 80: Germany Market Share, By Services, 2021
Figure 81: Germany Market Share, By End Use, 2021
Figure 82: U.K. Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 83: U.K. Market Share, By Services, 2021
Figure 84: U.K. Market Share, By End Use, 2021
Figure 85: France Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 86: France Market Share, By Services, 2021
Figure 87: France Market Share, By End Use, 2021
Figure 88: Italy Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 89: Italy Market Share, By Services, 2021
Figure 90: Italy Market Share, By End Use, 2021
Figure 91: BENELUX Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 92: BENELUX Market Share, By Services, 2021
Figure 93: BENELUX Market Share, By End Use, 2021
Figure 94: Nordic Countries Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 95: Nordic Countries Market Share, By Services, 2021
Figure 96: Nordic Countries Market Share, By End Use, 2021
Figure 97: China Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 98: China Market Share, By Services, 2021
Figure 99: China Market Share, By End Use, 2021
Figure 100: Japan Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 101: Japan Market Share, By Services, 2021
Figure 102: Japan Market Share, By End Use, 2021
Figure 103: South Korea Market Value (US$ Mn) and Forecast,2022 to 2032
Figure 104: South Korea Market Share, By Services, 2021
Figure 105: South Korea Market Share, By End Use, 2021
Figure 106: GCC Countries Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 107: GCC Countries Market Share, By Services, 2021
Figure 108: GCC Countries Market Share, By End Use, 2021
Figure 109: South Africa Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 110: South Africa Market Share, By Services, 2021
Figure 111: South Africa Market Share, By End Use, 2021
Figure 112: Turkey Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 113: Turkey Market Share, By Services, 2021
Figure 114: Turkey Market Share, By End Use, 2021
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How opportunistic will the biotechnology & pharmaceutical services outsourcing market be in North America?
North America will account for 53% of global biotechnology & pharmaceutical services demand.
What is the predicted value CAR for the market from 2022 to 2032?
From 2022 to 2032, the market is projected to expand at a 5% value CAGR, as per Fact.MR.
What is the projected market value for biotechnology & pharmaceutical services outsourcing in 2032?
By 2032, biotechnology & pharmaceutical services outsourcing market demand is expected to reach US$ 112.31 Billion.
What is the anticipated market value for biotechnology & pharmaceutical services outsourcing in 2022?
By 2022, demand for biotechnology & pharmaceutical services outsourcing is forecast to be valued at US$ 70 Billion.
What was the market worth for biotechnology & pharmaceutical services outsourcing in 2021?
As of 2021, the market for biotechnology & pharmaceutical services outsourcing was valued at US$ 65 Billion.
Biotechnology & Pharmaceutical Services Outsourcing Market